Trial Profile
Pharmacokinetic Study of ASP1517 - Evaluation of the Effect of Kremezin® on the Pharmacokinetics of ASP1517 in Non-elderly Healthy Adult Male Subjects, When Administered Concomitantly or in a Time Separated Manner.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Roxadustat (Primary) ; Charcoal
- Indications Anaemia; Chemotherapy-induced anaemia
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 01 May 2016 Status changed from recruiting to completed.
- 16 Mar 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 03 Mar 2016 New trial record